Nov 9, 2020 | 2020, Past Events
Philogen will be attending the PEGS Europe Virtual Conference from November 9 to 12, 2020. Co-founder and Chief Scientific Officer, Prof. Dario Neri will give a Keynote Presentation in the Tumor Microenvironment Session (Immunotherapy Stream) on November 10 with the...Nov 2, 2020 | 2020, Past Events
Philogen will be attending the Next Generation Protein Therapeutics & Bioconjugates Summit from November 2 to 5, 2020. Co-founder and Chief Scientific Officer, Prof. Dario Neri will give a Keynote Lecture with the title: Cancer Therapy Using Antibody-Cytokine...Oct 8, 2020 | 2020, Press Releases, Scientific
PRESS RELEASESep 15, 2020 | 2020, Past Events
Philogen will be attending the World ADC Digital Conference from September 15 to 18, 2020. Co-founder and Chief Scientific Officer, Prof. Dario Neri will give a Plenary Lecture on: “Small Molecule-drug Conjugates (SMDCs) & ADCs: A Comparative...Aug 20, 2020 | 2020, Press Releases, Scientific
Our co-founder and Chief Scientific Officer, Prof. Dario Neri will join Philogen in a full time capacity. His professional path is featured on the ETH Zurich web site. Read the full story here. Always ask the important questionsJul 17, 2020 | 2020, Press Releases, Scientific
Philogen announces a publication entitled: “A microdosing study with 99mTc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients” Link to Paper
Recent Comments